Win 49596-finasteride method of use and compositions

摘要

The method of use of a combination of the antiandrogen (5 alpha ,17 alpha )-1'-(methylsulfonyl)-1'H-pregn-20-yno[3,2-c]pyrazol-17-ol (Win 49596) and the 5 alpha -reductase inhibitor (5 alpha ,17 beta )-N-(1,1-dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide (finasteride) for treating prostate disease in a male mammal and pharmaceutical compositions thereof are disclosed.